<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03615209</url>
  </required_header>
  <id_info>
    <org_study_id>608/2017BO1</org_study_id>
    <nct_id>NCT03615209</nct_id>
  </id_info>
  <brief_title>Effect of Vagus Stimulation on Peripheral Glucose Metabolism</brief_title>
  <official_title>Effekte Der Transkutanen Aurikularen Vagus-Nervenstimulation (tVNS) Auf Die Postprandiale Stoffwechselregulation im Menschen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two important mechanisms play a major role in the pathogenesis of type 2 diabetes: insulin
      resistance of the target tissues and the impaired insulin secretion from pancreatic β-cells.
      Postprandial factors (such as insulin) are perceived by the human brain and induce signals
      that regulate glucose metabolism via the parasympathetic nervous system.

      Transcutaneous auricular vagus nerve stimulation (tVNS) can be used on the outer ear to
      stimulate the auricular branch of the vagus nerve in humans. Heart rate variability (HRV) in
      healthy people can be significantly increased via tVNS, indicating a shift from sympathetic
      activity to parasympathetic activity.

      The hypothesis is that this postprandial shift results in a change in peripheral glucose
      metabolism. In turn, the increased parasympathetic activity could potentially result in a
      change in postprandial insulin sensitivity or secretion.

      To test this hypothesis, this study investigates the effect of vagal stimulation versus sham
      stimulation on insulin sensitivity, on insulin secretion, glucose tolerance, resting energy
      expenditure, and on parasympathetic tone (analysis of heart rate variability).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 25, 2018</start_date>
  <completion_date type="Actual">December 20, 2018</completion_date>
  <primary_completion_date type="Actual">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Whole body insulin sensitivity</measure>
    <time_frame>0-120 min</time_frame>
    <description>Insulin sensitivity will be assessed by a 75g OGTT.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin secretion</measure>
    <time_frame>0-120 min</time_frame>
    <description>Insulin secretion will be assessed by a 75g OGTT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose tolerance</measure>
    <time_frame>0-120 min</time_frame>
    <description>Glucose tolerance will be assessed by a 75g OGTT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting energy expenditure</measure>
    <time_frame>140-160 min. after start of stimulation</time_frame>
    <description>Resting energy expenditure will be assessed by indirect calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>-30 - 120 min</time_frame>
    <description>Heart rate variability will be assessed from continuous ecg recordings</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Insulin Resistance</condition>
  <condition>Glucose Intolerance</condition>
  <arm_group>
    <arm_group_label>Transauricular vagus nerve stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non invasive vagus nerve stimulation will be conducted with Cerbomed NEMOS via the left ear.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transauricular sham stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Non invasive sham stimulation will be conducted with Cerbomed NEMOS via the left ear lobe.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transauricular vagus nerve stimulation</intervention_name>
    <description>Stimulation will be performed for 150 minutes (throughout the entire OGTT).</description>
    <arm_group_label>Transauricular vagus nerve stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transauricular sham stimulation</intervention_name>
    <description>Sham stimulation will be performed for 150 minutes (throughout the entire OGTT)</description>
    <arm_group_label>Transauricular sham stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HbA1c &lt;6.5%

          -  Must be able to understand the explanations of the study and the instructions

        Exclusion Criteria:

          -  Any relevant (according to investigator's judgment) cardiovascular disease

          -  Neurological and psychiatric disorders

          -  Diabetes mellitus

          -  Active implants (e.g. pacemaker, cochlear implant, cerebral shunt)

          -  asthma

          -  skin diseases on the ear
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Heni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Tuebingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Tuebingen, Department of Internal Medicine IV</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 30, 2018</study_first_submitted>
  <study_first_submitted_qc>July 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2018</study_first_posted>
  <last_update_submitted>January 9, 2019</last_update_submitted>
  <last_update_submitted_qc>January 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Due to ethical restrains, we will not be able to share patient level data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

